Charles Schwab Investment Management Inc Gelesis Holdings, Inc. Transaction History

Charles Schwab Investment Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.22 - $0.51 $3,681 - $8,533	-16,733 Reduced 32.32%	35,034 $10,000
Q3 2022 Nov 14, 2022	BUY	$0.08 - $1.34 $1,070 - $17,922	13,375 Added 34.84%	51,767 $56,000
Q2 2022 Aug 15, 2022	BUY	N/A	21,659 Added 129.44%	38,392 $60,000
Q1 2022 May 13, 2022	BUY	N/A	16,733 New	16,733 $76,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.